Personalizing CLL Treatment Options: Clinical Insights and Strategies to Improve Care

This comprehensive program gathers CLL management insights from our distinguished CLL experts and features education on emerging and established treatment strategies enhanced by a decision support tool for individualizing these treatments to your patients. All aspects of this program are designed to complement each other including the interactive treatment decision aid expert commentaries and an expert-authored module with downloadable slideset.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Supporters

This activity is supported by educational grants from

Acerta Pharma AstraZeneca Group

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics an AbbVie Company